Samfara

CompanyUnited Kingdom· Pharma

European life sciences investment firm.

Minutes holds 1 development and 1 deal naming Samfara, recorded from October 2026.

Intelligence

Deals in Minutes

Deals naming Samfara
Company	Deal	Amount	Counterparties	Date ↓	Status
Chr. Olesen SynthesisPharma	Buyout	Undisclosed	Acquired by SamfaraSold by Chr. Olesen, Signet Healthcare Partners	2 Oct	Closed

Chr. Olesen SynthesisUndisclosed
Buyout by Samfara +2
Pharma · 2 Oct · Closed

Showing 1–1 of 1

Acquisitions in Minutes

Chr. Olesen SynthesisBuyout · ClosedOct 02, 2026

Activity

Samfara

Investor Samfara buys Danish drug ingredient maker Chr. Olesen Synthesis

Deal · BuyoutSamfara, Chr. Olesen Synthesis, +1Pharma2 OctPR Newswire +4

Elsewhere in Pharma

Past 3 months in Activity →

Aurora Cannabis again tells shareholders to reject Curaleaf's revised hostile bid

M&AAurora Cannabis, Curaleaf, +1Pharma14 OctPR Newswire

GSK to invest more than $800 million in a Pennsylvania manufacturing hub

ExpansionGSKPharma13 OctManufacturing Dive